FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 64 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,370,600 | -29.0% | 12,674,120 | 0.0% | 4.60% | +15.5% |
| Q2 2023 | $89,225,805 | +13.5% | 12,674,120 | 0.0% | 3.98% | +30.4% |
| Q1 2023 | $78,579,544 | -2.8% | 12,674,120 | 0.0% | 3.05% | +18.3% |
| Q4 2022 | $80,860,886 | -25.6% | 12,674,120 | 0.0% | 2.58% | -43.6% |
| Q3 2022 | $108,744,000 | -36.9% | 12,674,120 | 0.0% | 4.58% | -29.5% |
| Q2 2022 | $172,368,000 | -10.7% | 12,674,120 | 0.0% | 6.49% | +43.3% |
| Q1 2022 | $193,027,000 | -33.4% | 12,674,120 | 0.0% | 4.53% | +1.1% |
| Q4 2021 | $289,857,000 | +64.2% | 12,674,120 | 0.0% | 4.48% | +142.3% |
| Q3 2021 | $176,551,000 | +30.6% | 12,674,120 | 0.0% | 1.85% | +7.1% |
| Q2 2021 | $135,233,000 | -19.0% | 12,674,120 | 0.0% | 1.73% | -35.4% |
| Q1 2021 | $167,045,000 | -35.0% | 12,674,120 | 0.0% | 2.68% | -42.8% |
| Q4 2020 | $256,905,000 | – | 12,674,120 | – | 4.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $13,458,000 | 4.37% |
| Birchview Capital, LP | 314,143 | $3,352,000 | 2.00% |
| Flagship Pioneering Inc. | 12,674,120 | $135,233,000 | 1.73% |
| Monashee Investment Management LLC | 530,581 | $5,661,000 | 0.68% |
| Artal Group S.A. | 1,720,720 | $18,360,000 | 0.37% |
| Alphabet Inc. | 500,901 | $5,345,000 | 0.11% |
| Casdin Capital, LLC | 216,216 | $2,307,000 | 0.06% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 84,000 | $896,000 | 0.01% |
| NewSquare Capital LLC | 5,000 | $53,000 | 0.01% |
| FMR LLC | 2,540,434 | $27,106,000 | 0.00% |